OR WAIT null SECS
July 25, 2022
The agency’s human medicines committee recommended drugs to treat breast cancer, lupus nephritis, type 2 diabetes and more.
A joint statement calling for international collaboration on the creation and use of real-world evidence has been published by the International Coalition of Medicines Regulatory Authorities.
July 20, 2022
Hospira has issued a voluntary nationwide recall for one lot of Propofol Injectable Emulsion, USP (containing benzyl alcohol), due to the potential presence of visible particulate.
July 19, 2022
TFF Pharmaceuticals is expanding its R&D operations with a new facility in Austin, Texas.
The PerkinElmer Flow Cytometry Instrument Concierge Services will provide biopharmaceutical labs with expert, on-site flow cytometry specialists.
Cytiva has acquired a new chromatography resins manufacturing site in the United States as part of its $1.5 billion capacity expansion investment.
July 18, 2022
Health Canada has authorized Moderna’s COVID-19 vaccine for use in young children aged six months to five years.
US legislators are devising strategies ahead of the reauthorization deadline for the FDA User Fee legislation.
Royalty Pharma is paying $1.6 billion for the royalty rights to Trelegy Ellipta, a treatment for COPD and asthma.
FDA has granted an Emergency Use Authorization to Novavax’s COVID-19 vaccine.